LU81319A1 - Nouvelles cephalosporines et leur preparation - Google Patents

Nouvelles cephalosporines et leur preparation

Info

Publication number
LU81319A1
LU81319A1 LU81319A LU81319A LU81319A1 LU 81319 A1 LU81319 A1 LU 81319A1 LU 81319 A LU81319 A LU 81319A LU 81319 A LU81319 A LU 81319A LU 81319 A1 LU81319 A1 LU 81319A1
Authority
LU
Luxembourg
Prior art keywords
preparation
new cephalosporins
cephalosporins
new
Prior art date
Application number
LU81319A
Other languages
English (en)
Inventor
D Livermore
C Ocallaghan
C Newall
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of LU81319A1 publication Critical patent/LU81319A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
LU81319A 1978-05-26 1979-05-25 Nouvelles cephalosporines et leur preparation LU81319A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2291178 1978-05-26
GB2291378 1978-05-26

Publications (1)

Publication Number Publication Date
LU81319A1 true LU81319A1 (fr) 1979-09-11

Family

ID=26256190

Family Applications (1)

Application Number Title Priority Date Filing Date
LU81319A LU81319A1 (fr) 1978-05-26 1979-05-25 Nouvelles cephalosporines et leur preparation

Country Status (27)

Country Link
US (2) US4258041A (fr)
AR (2) AR228726A1 (fr)
AT (1) AT370420B (fr)
AU (1) AU524671B2 (fr)
CA (1) CA1127633A (fr)
CH (2) CH649556A5 (fr)
DE (1) DE2921316C2 (fr)
DK (1) DK157685C (fr)
ES (2) ES480914A1 (fr)
FI (2) FI67555C (fr)
FR (2) FR2426695A1 (fr)
HK (1) HK40183A (fr)
IE (2) IE49172B1 (fr)
IL (3) IL57400A (fr)
IT (1) IT1116198B (fr)
KE (1) KE3252A (fr)
LU (1) LU81319A1 (fr)
MY (1) MY8400017A (fr)
NL (2) NL176855C (fr)
NO (2) NO155347C (fr)
NZ (2) NZ190558A (fr)
PH (1) PH16961A (fr)
PT (2) PT69669A (fr)
SE (2) SE438507B (fr)
SG (1) SG58382G (fr)
SI (2) SI7911231A8 (fr)
YU (2) YU41635B (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2466469A1 (fr) * 1979-10-02 1981-04-10 Glaxo Group Ltd Bischlorhydrate de cephalosporine, son procede de preparation et ses applications, notamment en therapeutique
FR2466467A1 (fr) * 1979-10-02 1981-04-10 Glaxo Group Ltd Pentahydrate de cephalosporine, son procede de preparation et son application en therapeutique
FR2466468A1 (fr) * 1979-10-02 1981-04-10 Glaxo Group Ltd Nouvelles cephalosporines, leur procede de preparation et leur application en therapeutique

Families Citing this family (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963542A (en) * 1976-09-08 1990-10-16 Takeda Chemical Industries, Ltd. Cephalosporin derivatives
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato
US4237128A (en) * 1979-04-12 1980-12-02 E. R. Squibb & Sons, Inc. 7-[2-(2-Amino-4-thiazolyl)-2-[(1-carboxy-1,1-dialkyl)alkoxyimino]acetamido]cephem sulfoxides
FR2457295A1 (fr) * 1979-05-25 1980-12-19 Glaxo Group Ltd Composes intermediaires pour la preparation de cephalosporines
US4332800A (en) * 1979-10-12 1982-06-01 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4338313A (en) * 1979-10-12 1982-07-06 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
DE3006888A1 (de) * 1980-02-23 1981-09-10 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
FR2476647A2 (fr) * 1980-02-26 1981-08-28 Roussel Uclaf Procede de preparation de derives de l'acide 2-(2-amino protege 4-thiazolyl) 2-alkoxyimino acetique isomere syn
US4252802A (en) * 1980-03-13 1981-02-24 E. R. Squibb & Sons, Inc. Hydroxamic acid derivatives of 7-[(2-amino-4-thiazolyl)-oximino] cephalosporins
GR75711B (fr) * 1980-06-30 1984-08-02 Sanofi Sa
US4443444A (en) * 1980-08-11 1984-04-17 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
EP0156118A1 (fr) * 1980-08-29 1985-10-02 Fujisawa Pharmaceutical Co., Ltd. Produits de départ pour la préparation de composés céphem et procédés pour leur préparation
NZ198350A (en) * 1980-09-25 1985-02-28 Toyama Chemical Co Ltd Cephalosporins and intermediates;pharmaceutical compositions
FR2494276A2 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouvelles vinyl-3 cephalosporines, et leur preparation
US4427677A (en) 1980-12-31 1984-01-24 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
JPS57144291A (en) * 1981-03-02 1982-09-06 Ajinomoto Co Inc Preparation of imidazoledicarboxylic acid derivative
US4336253A (en) * 1981-03-11 1982-06-22 Eli Lilly And Company Cephalosporin antibiotics
JPS6011917B2 (ja) * 1981-04-09 1985-03-28 山之内製薬株式会社 新規なセファロスポリン化合物
DE3118732A1 (de) * 1981-05-12 1982-12-02 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
GR75487B (fr) * 1981-06-22 1984-07-23 Fujisawa Pharmaceutical Co
US4406898A (en) * 1981-09-08 1983-09-27 Eli Lilly And Company Oxazole and oxadiazole cephalosporins
US4430499A (en) 1981-09-08 1984-02-07 Eli Lilly And Company 7-[2-(2-Aminooxazol-4-yl)-2-(oximino)acetamido]cephalosporin antibiotics
US4382931A (en) * 1981-09-08 1983-05-10 Eli Lilly And Company 3'-Substituted quinolinium cephalosporins
US4382932A (en) * 1981-09-08 1983-05-10 Eli Lilly And Company Isoquinolinium substituted cephalosporins
US4577014A (en) * 1981-09-08 1986-03-18 Eli Lilly And Company Thieno and furopyridinium-substituted cephalosporins
US4436912A (en) 1981-09-08 1984-03-13 Eli Lilly And Company 7-[2-(2-Aminooxazol-4-yl)-2-(oximino)acetamido cephalosporin antibiotics and intermediates therefor
JPS5859991A (ja) * 1981-09-14 1983-04-09 Fujisawa Pharmaceut Co Ltd 新規セフェム化合物
US4402955A (en) * 1981-10-02 1983-09-06 Eli Lilly And Company Dioximino cephalosporin antibiotics
US4401668A (en) * 1981-10-02 1983-08-30 Eli Lilly And Company Pyrazinium substituted cephalosporins
US4450270A (en) * 1981-10-02 1984-05-22 Eli Lilly And Company Dioximino cephalosporin antibiotics
US4388316A (en) * 1981-10-02 1983-06-14 Eli Lilly And Company Amino-substituted oxazole, oxadiazole and isoxazole-substituted cephalosporins
US4379787A (en) * 1981-10-02 1983-04-12 Eli Lilly And Company Oximino-substituted cephalosporin compounds
US4406887A (en) * 1981-10-13 1983-09-27 Bristol-Myers Company Method for treating resistant bacteria including anaerobes
US4510312A (en) * 1981-11-13 1985-04-09 Glaxo Group Limited Manufacture of antibiotics
ATE14728T1 (de) * 1981-11-13 1985-08-15 Glaxo Group Ltd Thiazol-derivate und ihre verwendung bei der herstellung von beta-lactam-antibiotika.
US4474954A (en) * 1981-12-07 1984-10-02 Bristol-Myers Company Intermediates for cephalosporin derivatives
US4394503A (en) * 1981-12-07 1983-07-19 Bristol-Myers Company Cephalosporin derivatives
US4501739A (en) * 1982-01-19 1985-02-26 Eli Lilly And Company Thieno and furopyridinium-substituted cephalosporins
DE3207840A1 (de) * 1982-03-04 1983-09-15 Hoechst Ag, 6230 Frankfurt "cephalosporinderivate und verfahren zu ihrer herstellung"
CA1213882A (fr) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporines
US4552696A (en) * 1982-04-09 1985-11-12 Bristol-Myers Company Carbapenem antibiotics
DE3375013D1 (en) * 1982-04-29 1988-02-04 Glaxo Group Ltd Thiazole derivative, process for its preparation and use in the preparation of beta-lactam antibiotics
DE3374410D1 (en) 1982-06-28 1987-12-17 Bristol Myers Co Cephalosporin derivatives, a process for the manufacture thereof and pharmaceutical compositions containing said derivatives
IL69246A (en) * 1982-08-07 1986-07-31 Tanabe Seiyaku Co 7-((2-aminothiazolyl-2-pyrrolidonyl or(piperidonyl)-oxyimino)acetamido)cephem carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
ES525492A0 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
EP0113568B1 (fr) * 1982-12-27 1990-04-04 Eli Lilly And Company Intermédiaires pour la préparation de ceftazidine, et procédé pour leur préparation
EP0115770B2 (fr) * 1983-01-07 1996-06-19 Takeda Chemical Industries, Ltd. Dérivés de thiazoles
US4486586A (en) * 1983-02-10 1984-12-04 Bristol-Myers Company Cephalosporin derivatives
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
DE3313816A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
DE3316797A1 (de) * 1983-05-07 1984-11-08 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von cephemverbindungen
DE3316798A1 (de) * 1983-05-07 1984-11-08 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von cephemverbindungen
US4540779A (en) * 1983-06-20 1985-09-10 Eli Lilly And Company Crystalline 7-(R)-amino-3-(1'pyridiniummethyl)-ceph-3-em-4-carboxylate monohydrochloride monohydrate compound
US4497811A (en) * 1983-07-01 1985-02-05 Seiji Shibahara 1-Oxadethiacephalosporin compound and antibacterial agent containing the _same
JPS6061528A (ja) * 1983-09-09 1985-04-09 ブリストル―マイヤーズ　スクイブ　カンパニー 嫌気性菌を包含する耐性バクテリアの処理法
AU566944B2 (en) * 1983-10-07 1987-11-05 Gist-Brocades N.V. Preparation of 3-cephem derivatives
JPS60178891A (ja) * 1984-02-24 1985-09-12 Kureha Chem Ind Co Ltd セファロスポリン誘導体及び該誘導体を含有する医薬
GB8406218D0 (en) * 1984-03-09 1984-04-11 Glaxo Group Ltd Process
US4537959A (en) * 1984-03-26 1985-08-27 Eli Lilly And Company Crystalline cephalosporin antibiotic salt
US4788185A (en) * 1984-04-23 1988-11-29 Takeda Chemical Industries, Ltd. Cephalosporin compounds
PH22107A (en) * 1984-06-07 1988-06-01 Takeda Chemical Industries Ltd 3-pyrazolo(1,5-a)pyrdinium cephem compounds
EP0166580A3 (fr) * 1984-06-25 1987-03-18 Eli Lilly And Company Préparation de ceftazidine
US4616080A (en) * 1984-07-02 1986-10-07 Eli Lilly And Company Simplified process of forming crystalline ceftazidime pentahydrate
US4626534A (en) * 1984-07-23 1986-12-02 Eli Lilly And Company Pharmaceutical formulation
IL76367A0 (en) * 1984-09-17 1986-01-31 Lilly Co Eli Improved process for cephalsporin intermediates
US4659813A (en) * 1984-11-08 1987-04-21 Eli Lilly And Company Crystallization process for ceftazidime derivative
GB8504072D0 (en) * 1985-02-18 1985-03-20 Fujisawa Pharmaceutical Co Cephem compounds
ATE89826T1 (de) * 1985-03-01 1993-06-15 Takeda Chemical Industries Ltd Antibakterielle verbindungen, ihre herstellung und verwendung.
US4703118A (en) * 1985-04-08 1987-10-27 Eli Lilly And Company Synthesis of 3-iodomethyl cephalosporins
US4692518A (en) * 1985-11-06 1987-09-08 Eli Lilly And Company Crystalline (7R)-7-amino-3-(1'-pyridiniummethyl)-3-cephem-4-carboxylate monohydrate compound
JPS62175489A (ja) * 1986-01-29 1987-08-01 Sanwa Kagaku Kenkyusho:Kk 新規なセフアロスポリン誘導体及びその塩、これらの製法並びに該化合物を有効成分とする感染症治療剤
US5359057A (en) * 1986-02-07 1994-10-25 Hoffmann-La Roche Inc. Acylation of amines
JPS63107989A (ja) * 1986-06-04 1988-05-12 Tanabe Seiyaku Co Ltd セファロスポリン化合物
AT387022B (de) * 1986-06-04 1988-11-25 Biochemie Gmbh Verfahren zur herstellung einer neuen kristallinen form eines cefalosporinderivats
IL82738A0 (en) * 1986-06-16 1987-12-20 Tanabe Seiyaku Co Cephalosporin compounds,their preparation and pharmaceutical compositions containing them
EP0282531B1 (fr) * 1986-09-10 1992-04-15 Biochemie Gesellschaft M.B.H. Forme cristalline stable d'un produit intermediaire de la cephalosporine
US4954624A (en) * 1986-10-07 1990-09-04 Sandoz Ltd. Process for the production of cephalosporin derivatives
US5021564A (en) * 1987-02-02 1991-06-04 Eli Lilly And Company Process for preparing ceftazidime pentahydrate
EP0278656B1 (fr) * 1987-02-02 1992-06-03 Eli Lilly And Company Procédé pour la préparation de pentahydrate de ceftazidime
EP0321562B1 (fr) * 1987-06-25 1993-11-24 Banyu Pharmaceutical Co., Ltd. Composes cristallins de cephalosporine, procede de preparation et produits intermediaires pour la preparation de ces composes
GB8802622D0 (en) * 1988-02-05 1988-03-02 Glaxo Group Ltd Chemical compound
IL92810A (en) * 1988-12-27 1994-12-29 Lilly Co Eli The process of acylation of the history of nectar and intermediate material for this process
US5194604A (en) * 1990-06-29 1993-03-16 E. R. Squibb & Sons, Inc. Process and intermediates for beta-lactams having aminothiazole(iminooxyacetic acid)acetic acid sidechains
KR940000112B1 (ko) * 1990-07-05 1994-01-05 주식회사 대웅제약 신규의 3-치환 세펨화합물 및 그의 제조방법
US5281589A (en) * 1991-06-15 1994-01-25 Cheil Foods & Chemicals, Inc. 3-fused pyridiniummethyl cephalosporins
KR100194994B1 (ko) * 1993-06-05 1999-06-15 손경식 새로운 세펨 화합물
US6472383B1 (en) 1994-04-25 2002-10-29 Smithkline Beecham P.L.C. Pharmaceutical formulations
WO1995028935A1 (fr) * 1994-04-25 1995-11-02 Smithkline Beecham Plc Formulations pharmaceutiques contenant un peneme inhibant une bêta-lactamase, en combination avec un antibiotique bêta-lactame, et leur utilisation dans le traitement d'infections bacteriennes
JPH09506112A (ja) * 1994-05-23 1997-06-17 コリア・インスティチュート・オブ・サイアンス・アンド・テクノロジー セファロスポリン化合物およびその製造方法
US5831085A (en) * 1997-01-16 1998-11-03 Lupin Laboratories Limited Process for manufacture of cephalosporin such as ceftazidime and intermediate thereof
IN189047B (fr) 1998-06-01 2002-12-14 Ranbaxy Lab Ltd
US6930983B2 (en) * 2000-03-15 2005-08-16 Texas Instruments Incorporated Integrated circuits, systems, apparatus, packets and processes utilizing path diversity for media over packet applications
KR100342600B1 (ko) 2000-03-06 2002-07-04 한미정밀화학주식회사 신규한 티아졸 화합물 및 그의 제조 방법
KR100392409B1 (ko) 2000-03-20 2003-07-22 한미정밀화학주식회사 신규한 티아졸 화합물을 이용한 세팔로스포린계항생물질의 제조 방법
US6911441B2 (en) * 2002-12-16 2005-06-28 Akzo Nobel N.V. Prolonged release pharmaceutical composition
CN1312158C (zh) * 2005-05-20 2007-04-25 天津市医药集团技术发展有限公司 一种头孢克肟的制备方法
WO2009049086A1 (fr) 2007-10-09 2009-04-16 Larry Sutton Inhibiteurs de bêta-lactamase à large spectre
CN101293891B (zh) * 2008-06-12 2011-01-12 齐鲁安替制药有限公司 头孢他啶中间体的制备方法
MX352760B (es) 2011-09-09 2017-12-07 Merck Sharp & Dohme Corp Star Metodos para tratar infecciones intrapulmonares.
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
ES2633964T3 (es) 2013-03-13 2017-09-26 Theravance Biopharma Antibiotics Ip, Llc Sales de clorhidrato de un compuesto antibiótico
US20140275000A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
MX2020004205A (es) 2013-03-15 2021-11-16 Merck Sharp & Dohme Llc Composiciones antibioticas de ceftolozano.
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
WO2015035376A2 (fr) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Traitement d'infections au moyen de ceftolozane/tazobactam chez des sujets ayant une fonction rénale altérée
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN106336418B (zh) * 2016-08-19 2019-02-01 上海上药新亚药业有限公司 一种头孢他啶盐酸盐的固相合成法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1399086A (en) 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
US4092477A (en) * 1971-05-14 1978-05-30 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(phenyl- or naphthylacetamido)] cephalosporins
US4093803A (en) * 1971-05-14 1978-06-06 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(thienyl-, furyl- or pyridylacetamido)] cephalosporins
US4079178A (en) * 1971-05-14 1978-03-14 Glaxo Laboratories Limited Cephalosporins having (α-etherified oximino) acylamido groups at the 7-position
US3971778A (en) * 1972-05-12 1976-07-27 Glaxo Laboratories Limited Cephalosporins having (α-etherified oximino)acylamido groups at the 7-position
US4017515A (en) * 1971-05-14 1977-04-12 Glaxo Laboratories Limited α-(Etherified oximino) carboxylic acids and acid chlorides
US4024137A (en) * 1971-05-14 1977-05-17 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(phenyl- or naphthylacetamido)] cephalosporins
US4033950A (en) * 1971-05-14 1977-07-05 Glaxo Laboratories Limited 3-Hydroxymethyl-7β-(2-alkoxy-or benzyloxyimino-2-arylacetamido)ceph-3-em-4-carboxylic acids and salts thereof
US4064346A (en) * 1971-05-14 1977-12-20 Glaxo Laboratories Limited 3-Acetoxymethyl-7β-(2-carboxy-methoxyimino-2-arylacetamido)ceph-3-em-4-carboxylic acids and salts thereof
US4024133A (en) * 1971-05-14 1977-05-17 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(thienyl-,furyl- or pyridylacetamido)]cephalosporins
GB1496757A (en) 1973-12-21 1978-01-05 Glaxo Lab Ltd Cephalosporin derivatives
US4144392A (en) * 1973-12-21 1979-03-13 Glaxo Laboratories Limited Cephalosporins having at position-7 a carboxy substituted α-etherified hydroxyimino-arylacetamido group and at position-3 the residue of a sulphur nucleophile
US4060686A (en) * 1973-12-21 1977-11-29 Janice Bradshaw Cephalosporins having a 7-(carboxy substituted α-etherified oximinoarylacetamido) group
US4095021A (en) * 1973-12-21 1978-06-13 Glaxo Laboratories Limited 3-Carbamoyloxymethyl or N-methyl-carbamoyloxymethyl-7-[2-carboxymethoxyimino-2-(fur-2-yl or thien-2-yl)acetamido]ceph-3-em-4-carboxylic acids and derivatives thereof
US4162360A (en) * 1973-12-21 1979-07-24 Glaxo Laboratories Limited 3-Carbamoyloxymethyl-7-substituted oximino acetamido cephalosporanic acid derivatives
US4032950A (en) * 1974-12-06 1977-06-28 Hughes Aircraft Company Liquid phase epitaxial process for growing semi-insulating gaas layers
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
US4165430A (en) * 1976-03-19 1979-08-21 Glaxo Laboratories Limited Cephalosporins having a 7-carboxy substituted α-etherified oximinoarylacetamido) group
US4166115A (en) * 1976-04-12 1979-08-28 Fujisawa Pharmaceutical Co., Ltd. Syn 7-oxoimino substituted derivatives of cephalosporanic acid
JPS52125188A (en) 1976-04-14 1977-10-20 Takeda Chem Ind Ltd Cephalosporin derivatives and their preparation
ZA781502B (en) 1977-03-14 1979-09-26 Fujisawa Pharmaceutical Co New cephem and cepham compounds and processes for preparation thereof
FR2384782A1 (fr) 1977-03-25 1978-10-20 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-acetoxymethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
DE2716677C2 (de) 1977-04-15 1985-10-10 Hoechst Ag, 6230 Frankfurt Cephemderivate und Verfahren zu ihrer Herstellung
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
ZA781870B (en) 1977-04-02 1979-03-28 Hoechst Ag Cephem derivatives and process for their manufacture
GB1602725A (en) 1977-04-27 1981-11-18 Glaxo Operations Ltd 7-(a-oxyiminoacetamido)-ceph-3-em-4-carboxylic acid derivatives
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato
US4237128A (en) * 1979-04-12 1980-12-02 E. R. Squibb & Sons, Inc. 7-[2-(2-Amino-4-thiazolyl)-2-[(1-carboxy-1,1-dialkyl)alkoxyimino]acetamido]cephem sulfoxides
US4394503A (en) * 1981-12-07 1983-07-19 Bristol-Myers Company Cephalosporin derivatives

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2466469A1 (fr) * 1979-10-02 1981-04-10 Glaxo Group Ltd Bischlorhydrate de cephalosporine, son procede de preparation et ses applications, notamment en therapeutique
FR2466467A1 (fr) * 1979-10-02 1981-04-10 Glaxo Group Ltd Pentahydrate de cephalosporine, son procede de preparation et son application en therapeutique
FR2466468A1 (fr) * 1979-10-02 1981-04-10 Glaxo Group Ltd Nouvelles cephalosporines, leur procede de preparation et leur application en therapeutique
DE3037104A1 (de) * 1979-10-02 1981-04-16 Glaxo Group Ltd., London Verbesserungen eines cephalosporinantibiotikums
DE3037102A1 (de) * 1979-10-02 1981-04-23 Glaxo Group Ltd., London Verbesserungen bei cephalosporinantibiotika

Also Published As

Publication number Publication date
IL57400A (en) 1982-08-31
YU223482A (en) 1983-04-30
CH646178A5 (de) 1984-11-15
US4258041A (en) 1981-03-24
IL59793A0 (en) 1980-06-30
NL176855B (nl) 1985-01-16
DK157685C (da) 1990-07-09
AR228726A1 (es) 1983-04-15
FR2426695A1 (fr) 1979-12-21
IE802453L (en) 1979-11-26
ES480915A1 (es) 1980-02-01
FR2445835B1 (fr) 1983-06-03
NZ190558A (en) 1982-05-31
YU123179A (en) 1983-01-21
IE49173B1 (en) 1985-08-21
IE791025L (en) 1979-11-26
AU524671B2 (en) 1982-09-30
ATA239281A (de) 1982-08-15
IL57400A0 (en) 1979-09-30
YU41635B (en) 1987-12-31
PH16961A (en) 1984-04-27
FR2445835A1 (fr) 1980-08-01
FI67555B (fi) 1984-12-31
US4600772A (en) 1986-07-15
NL176855C (nl) 1985-06-17
FR2426695B1 (fr) 1982-06-11
PT69669A (en) 1979-06-01
NL8001348A (nl) 1980-06-30
NZ193326A (en) 1982-05-31
YU43097B (en) 1989-02-28
IL59793A (en) 1982-08-31
CH649556A5 (de) 1985-05-31
NO155347B (no) 1966-12-08
FI791678A (fi) 1979-11-27
ES480914A1 (es) 1980-02-01
AR229883A1 (es) 1983-12-30
KE3252A (en) 1983-01-28
SE8402887D0 (sv) 1984-05-28
DE2921316A1 (de) 1979-12-06
IE49172B1 (en) 1985-08-21
DK216779A (da) 1979-11-27
SE438507B (sv) 1985-04-22
IT1116198B (it) 1986-02-10
SG58382G (en) 1983-09-02
NL7904122A (nl) 1979-11-28
NO155347C (no) 1987-03-18
SI8212234A8 (en) 1997-06-30
HK40183A (en) 1983-10-21
SE7904576L (sv) 1980-02-11
MY8400017A (en) 1984-12-31
PT69670A (en) 1979-06-01
NO850153L (no) 1979-11-27
FI67705B (fi) 1985-01-31
AT370420B (de) 1983-03-25
FI67555C (fi) 1985-04-10
CA1127633A (fr) 1982-07-13
FI67705C (fi) 1985-05-10
SE8402887L (sv) 1984-05-28
SI7911231A8 (en) 1997-06-30
DE2921316C2 (de) 1982-09-16
NO791731L (no) 1979-11-27
FI801609A (fi) 1980-05-19
AU4742279A (en) 1979-11-29
DK157685B (da) 1990-02-05

Similar Documents

Publication Publication Date Title
LU81319A1 (fr) Nouvelles cephalosporines et leur preparation
FI791844A (fi) Kontaktlinser med hoeg permeabilitet av gaser
MA19845A1 (fr) Nouvelles piperidinamines et leur preparation
LU81320A1 (fr) Nouvelles cephalosporines et leur preparation
FI790422A (fi) Blekning av lignocellulosamaterial med peroxidhaltiga blekmedel
FI791068A (fi) Oeverdragskomposition med denna komposition oeverdragna glasfibrer och anvaendning av dessa foer plastarmering
BE883415A (fr) Nouvelles thiovinyl-3 cephalosporines, leur preparation et les compositions qui les contiennent
FI784046A (fi) Foerfarande foer faestning av med en metallisk expansionsholk foersedd expansionspropp
PT71278A (fr) Nouvelles cephalosporines et leur preparation
FR2315933A1 (fr) Nouvelles cephalosporines, leur preparation et leur emploi
FI790241A (fi) Foerfarande foer formande av glasfiberdispersioner med katjoniska kvaternaerammoniumytaktiva aemnen med aotminstone tvao laonga kedjegrupper
BE880068A (fr) Nouvelles cephalosporines et leur preparation
IT7949302A0 (it) Antibiotici e loro preparazione
FI791127A (fi) Elektronkanon med hoeg spaenning och liten foerstoringsfaktor
BE877021A (fr) Nouvelles cephalosporines et leur preparation
BE875592A (fr) Derives de pyrrolidinecarboxaldehyde et de piperidinecarboxaldehyde et leur preparation
BE880182A (fr) Nouvelles azepino (1,2,3-1m)-beta-carbolines et leur preparation
BE886534A (fr) Cephalosporines substituees, leur preparation et leur emploi
BE875371A (fr) Procede de preparation de 3-carbamoyloxymethyl-cephalosporines et nouvelles cephalosporines
SE8001100L (sv) Beta-laktamforeningar
IT1203687B (it) Arilalchil-e arilossialchil-fosfonati e loro preparazione
FI793613A (fi) Framstaellning av etylenkopolymerer med hoeg densitet i en fluidationsbaeddreaktor
BE885487A (fr) Nouvelles cephalosporines et leur preparation
BE866422R (fr) Nouvelles cephalosporines, leur preparation et compositions en contenant
BE833640A (fr) Nouvelles cephalosporines et leur preparation

Legal Events

Date Code Title Description
DT Application date
TA Annual fee